{"result": "(\"entity\"<|>TORRES TORRES B<|>PERSON<|>Torres Torres B is an author who contributed to the work on parenteral nutrition and is involved in clinical nutrition research.)\n##\n(\"entity\"<|>LÓPEZ GÓMEZ JJ<|>PERSON<|>López Gómez JJ is an author who contributed to the work on parenteral nutrition and is involved in clinical nutrition research.)\n##\n(\"entity\"<|>GÓMEZ HOYOS E<|>PERSON<|>Gómez Hoyos E is an author who contributed to the work on parenteral nutrition and is involved in clinical nutrition research.)\n##\n(\"entity\"<|>ORTOLÁ BUIGES A<|>PERSON<|>Ortolá Buiges A is an author who contributed to the work on parenteral nutrition and is involved in clinical nutrition research.)\n##\n(\"entity\"<|>DE LUIS ROMÁN DA<|>PERSON<|>De Luis Román DA is an author who contributed to the work on parenteral nutrition and is involved in clinical nutrition research.)\n##\n(\"entity\"<|>GUERRERO D<|>PERSON<|>Guerrero D is an author who contributed to the work on parenteral nutrition and is involved in clinical nutrition research.)\n##\n(\"entity\"<|>GARCÍA LUNA PP<|>PERSON<|>García Luna PP is an author who contributed to the work on parenteral nutrition and is involved in clinical nutrition research.)\n##\n(\"entity\"<|>OLVEIRA FUSTER G<|>PERSON<|>Olveira Fuster G is an author who contributed to the work on parenteral nutrition and is involved in clinical nutrition research.)\n##\n(\"entity\"<|>SOCIEDAD ESPAÑOLA DE ENDOCRINOLOGÍA Y NUTRICIÓN<|>ORGANIZATION<|>The Sociedad Española de Endocrinología y Nutrición is an organization focused on endocrinology and nutrition, which published a manual on parenteral nutrition.)\n##\n(\"entity\"<|>AULA MÉDICA<|>ORGANIZATION<|>Aula Médica is a publishing house that published a book on clinical nutrition and metabolism.)\n##\n(\"entity\"<|>FARM HOSP<|>ORGANIZATION<|>Farm Hosp is a journal that published research related to parenteral nutrition.)\n##\n(\"relationship\"<|>TORRES TORRES B<|>SOCIEDAD ESPAÑOLA DE ENDOCRINOLOGÍA Y NUTRICIÓN<|>Torres Torres B is an author contributing to the manual published by the Sociedad Española de Endocrinología y Nutrición<|>7)\n##\n(\"relationship\"<|>LÓPEZ GÓMEZ JJ<|>SOCIEDAD ESPAÑOLA DE ENDOCRINOLOGÍA Y NUTRICIÓN<|>López Gómez JJ is an author contributing to the manual published by the Sociedad Española de Endocrinología y Nutrición<|>7)\n##\n(\"relationship\"<|>GÓMEZ HOYOS E<|>SOCIEDAD ESPAÑOLA DE ENDOCRINOLOGÍA Y NUTRICIÓN<|>Gómez Hoyos E is an author contributing to the manual published by the Sociedad Española de Endocrinología y Nutrición<|>7)\n##\n(\"relationship\"<|>ORTOLÁ BUIGES A<|>SOCIEDAD ESPAÑOLA DE ENDOCRINOLOGÍA Y NUTRICIÓN<|>Ortolá Buiges A is an author contributing to the manual published by the Sociedad Española de Endocrinología y Nutrición<|>7)\n##\n(\"relationship\"<|>DE LUIS ROMÁN DA<|>SOCIEDAD ESPAÑOLA DE ENDOCRINOLOGÍA Y NUTRICIÓN<|>De Luis Román DA is an author contributing to the manual published by the Sociedad Española de Endocrinología y Nutrición<|>7)\n##\n(\"relationship\"<|>GUERRERO D<|>FARM HOSP<|>Guerrero D is an author contributing to the research published in Farm Hosp related to parenteral nutrition<|>6)\n##\n(\"relationship\"<|>GARCÍA LUNA PP<|>FARM HOSP<|>García Luna PP is an author contributing to the research published in Farm Hosp related to parenteral nutrition<|>6)\n##\n(\"relationship\"<|>OLVEIRA FUSTER G<|>FARM HOSP<|>Olveira Fuster G is an author contributing to the research published in Farm Hosp related to parenteral nutrition<|>6)\n##\n(\"relationship\"<|>TORRES TORRES B<|>AULA MÉDICA<|>Torres Torres B is an author contributing to the book published by Aula Médica on clinical nutrition<|>7)\n##\n(\"relationship\"<|>LÓPEZ GÓMEZ JJ<|>AULA MÉDICA<|>López Gómez JJ is an author contributing to the book published by Aula Médica on clinical nutrition<|>7)\n##\n(\"relationship\"<|>GÓMEZ HOYOS E<|>AULA MÉDICA<|>Gómez Hoyos E is an author contributing to the book published by Aula Médica on clinical nutrition<|>7)\n##\n(\"relationship\"<|>ORTOLÁ BUIGES A<|>AULA MÉDICA<|>Ortolá Buiges A is an author contributing to the book published by Aula Médica on clinical nutrition<|>7)\n##\n(\"relationship\"<|>DE LUIS ROMÁN DA<|>AULA MÉDICA<|>De Luis Román DA is an author contributing to the book published by Aula Médica on clinical nutrition<|>7)\n<|COMPLETE|>", "input": "\n-Goal-\nGiven a text document that is potentially relevant to this activity and a list of entity types, identify all entities of those types from the text and all relationships among the identified entities.\n \n-Steps-\n1. Identify all entities. For each identified entity, extract the following information:\n- entity_name: Name of the entity, capitalized\n- entity_type: One of the following types: [organization,person,geo,event]\n- entity_description: Comprehensive description of the entity's attributes and activities\nFormat each entity as (\"entity\"<|><entity_name><|><entity_type><|><entity_description>)\n \n2. From the entities identified in step 1, identify all pairs of (source_entity, target_entity) that are *clearly related* to each other.\nFor each pair of related entities, extract the following information:\n- source_entity: name of the source entity, as identified in step 1\n- target_entity: name of the target entity, as identified in step 1\n- relationship_description: explanation as to why you think the source entity and the target entity are related to each other\n- relationship_strength: a numeric score indicating strength of the relationship between the source entity and target entity\n Format each relationship as (\"relationship\"<|><source_entity><|><target_entity><|><relationship_description><|><relationship_strength>)\n \n3. Return output in English as a single list of all the entities and relationships identified in steps 1 and 2. Use **##** as the list delimiter.\n \n4. When finished, output <|COMPLETE|>\n \n######################\n-Examples-\n######################\nExample 1:\nEntity_types: ORGANIZATION,PERSON\nText:\nThe Verdantis's Central Institution is scheduled to meet on Monday and Thursday, with the institution planning to release its latest policy decision on Thursday at 1:30 p.m. PDT, followed by a press conference where Central Institution Chair Martin Smith will take questions. Investors expect the Market Strategy Committee to hold its benchmark interest rate steady in a range of 3.5%-3.75%.\n######################\nOutput:\n(\"entity\"<|>CENTRAL INSTITUTION<|>ORGANIZATION<|>The Central Institution is the Federal Reserve of Verdantis, which is setting interest rates on Monday and Thursday)\n##\n(\"entity\"<|>MARTIN SMITH<|>PERSON<|>Martin Smith is the chair of the Central Institution)\n##\n(\"entity\"<|>MARKET STRATEGY COMMITTEE<|>ORGANIZATION<|>The Central Institution committee makes key decisions about interest rates and the growth of Verdantis's money supply)\n##\n(\"relationship\"<|>MARTIN SMITH<|>CENTRAL INSTITUTION<|>Martin Smith is the Chair of the Central Institution and will answer questions at a press conference<|>9)\n<|COMPLETE|>\n\n######################\nExample 2:\nEntity_types: ORGANIZATION\nText:\nTechGlobal's (TG) stock skyrocketed in its opening day on the Global Exchange Thursday. But IPO experts warn that the semiconductor corporation's debut on the public markets isn't indicative of how other newly listed companies may perform.\n\nTechGlobal, a formerly public company, was taken private by Vision Holdings in 2014. The well-established chip designer says it powers 85% of premium smartphones.\n######################\nOutput:\n(\"entity\"<|>TECHGLOBAL<|>ORGANIZATION<|>TechGlobal is a stock now listed on the Global Exchange which powers 85% of premium smartphones)\n##\n(\"entity\"<|>VISION HOLDINGS<|>ORGANIZATION<|>Vision Holdings is a firm that previously owned TechGlobal)\n##\n(\"relationship\"<|>TECHGLOBAL<|>VISION HOLDINGS<|>Vision Holdings formerly owned TechGlobal from 2014 until present<|>5)\n<|COMPLETE|>\n\n######################\nExample 3:\nEntity_types: ORGANIZATION,GEO,PERSON\nText:\nFive Aurelians jailed for 8 years in Firuzabad and widely regarded as hostages are on their way home to Aurelia.\n\nThe swap orchestrated by Quintara was finalized when $8bn of Firuzi funds were transferred to financial institutions in Krohaara, the capital of Quintara.\n\nThe exchange initiated in Firuzabad's capital, Tiruzia, led to the four men and one woman, who are also Firuzi nationals, boarding a chartered flight to Krohaara.\n\nThey were welcomed by senior Aurelian officials and are now on their way to Aurelia's capital, Cashion.\n\nThe Aurelians include 39-year-old businessman Samuel Namara, who has been held in Tiruzia's Alhamia Prison, as well as journalist Durke Bataglani, 59, and environmentalist Meggie Tazbah, 53, who also holds Bratinas nationality.\n######################\nOutput:\n(\"entity\"<|>FIRUZABAD<|>GEO<|>Firuzabad held Aurelians as hostages)\n##\n(\"entity\"<|>AURELIA<|>GEO<|>Country seeking to release hostages)\n##\n(\"entity\"<|>QUINTARA<|>GEO<|>Country that negotiated a swap of money in exchange for hostages)\n##\n##\n(\"entity\"<|>TIRUZIA<|>GEO<|>Capital of Firuzabad where the Aurelians were being held)\n##\n(\"entity\"<|>KROHAARA<|>GEO<|>Capital city in Quintara)\n##\n(\"entity\"<|>CASHION<|>GEO<|>Capital city in Aurelia)\n##\n(\"entity\"<|>SAMUEL NAMARA<|>PERSON<|>Aurelian who spent time in Tiruzia's Alhamia Prison)\n##\n(\"entity\"<|>ALHAMIA PRISON<|>GEO<|>Prison in Tiruzia)\n##\n(\"entity\"<|>DURKE BATAGLANI<|>PERSON<|>Aurelian journalist who was held hostage)\n##\n(\"entity\"<|>MEGGIE TAZBAH<|>PERSON<|>Bratinas national and environmentalist who was held hostage)\n##\n(\"relationship\"<|>FIRUZABAD<|>AURELIA<|>Firuzabad negotiated a hostage exchange with Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>AURELIA<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>FIRUZABAD<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>ALHAMIA PRISON<|>Samuel Namara was a prisoner at Alhamia prison<|>8)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>MEGGIE TAZBAH<|>Samuel Namara and Meggie Tazbah were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>DURKE BATAGLANI<|>Samuel Namara and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>DURKE BATAGLANI<|>Meggie Tazbah and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>FIRUZABAD<|>Samuel Namara was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>FIRUZABAD<|>Meggie Tazbah was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>DURKE BATAGLANI<|>FIRUZABAD<|>Durke Bataglani was a hostage in Firuzabad<|>2)\n<|COMPLETE|>\n\n######################\n-Real Data-\n######################\nEntity_types: organization,person,geo,event\nText: •  No añadir electrolitos a la emulsión lipídica.\n         • Torres Torres B, López Gómez JJ, Gómez Hoyos E, Ortolá Buiges A, de Luis Román DA. Nutrición parenteral. En: de Luis DA, Bellido          •  Emplear solo gluconato cálcico para evitar errores de cálculo con el cloruro cálcico.\n           Guerrero D, García Luna PP, Olveira Fuster G, eds. Dietoterapia, nutrición clínica y metabolismo. 3.ª ed. Toledo: Aula Médica; 2017.\n           p. 763-88.                                                                                                                                Referencias:\n                                                                                                                                                     • Bretón Lesmes I, Motilla de la Cámara M, Cuerda Compés C. Nutrición parenteral. Manual de Endocrinología y Nutrición. Madrid:\n                                                                                                                                                       Sociedad Española de Endocrinología y Nutrición; 2016.\n                                                                                                                                                     • Gomis P, Rodríguez I, Inaraja MT, Vázquez A, Martínez-Vázquez MJ, Calvo MV, et al. Proceso 4. Formulación y elaboración.\n         En la administración de la nutrición parenteral, indique cuál de las siguientes                                                               Farm Hosp. 2009;33(Supl 1):36-48.\n     26  opciones es verdadera:\n         A. Hay que valorar la compatibilidad de un fármaco antes de incluirlo en la emulsión,                                                   27  Señale la respuesta correcta sobre nutrición parenteral:\n             pero no es necesario si se administra en Y con la nutrición parenteral.                                                                 A. Todas las emulsiones lipídicas en la nutrición parenteral incluyen ácido oleico y esteárico.\n         B. El pH no influye en la estabilidad de la emulsión lipídica.                                                                              B. Todas las emulsiones lipídicas en la nutrición parenteral aportan fosfato procedente\n         C. Se deben mezclar los aminoácidos con las grasas en primer lugar y posteriormente                                                             de los fosfolípidos que se usan como emulgentes.\n             añadir la glucosa.                                                                                                                      C. Siempre se seleccionan emulsiones lipídicas sin vitaminas liposolubles para evitar\n         D.  En las fórmulas de nutrición parenteral se recomienda el uso de gluconato cálcico sobre                                                     acúmulos tóxicos de las mismas.\n             cloruro cálcico.                                                                                                                        D.  La mayor ventaja de las emulsiones lipídicas de triglicéridos de cadena larga es su\n                                                                                                                                                         riqueza en ácidos grasos ω-6.\n\n\n\n220                                                                                                                                                                                                                                                                             221\n---\n                                                                                                                                                                                                                                        NUTRICIÓN                           4\n\n\n\n         COMENTARIO                                                                                                                                     •  Hipo-hiperfosfatemia.\n         Las emulsiones lipídicas habituales están compuestas por una emulsión de aceite de soja,                                                       •  Hipo-hipermagnesemia.\n         coco, palma o pescado, a la que se añaden fosfolípidos como emulsionante y glicerol para                                                    7.  Alteraciones hepatobiliares:\n         isotonizar. La mezcla resultante tiene concentraciones entre el 10% y el 30%, según la rela-                                                    •  La esteatosis hepática           es frecuente tras el inicio de la NP, y, aunque inicialmente\n         ción fosfolípido/triglicéridos. Las principales emulsiones lipídicas son:                                                                          es reversible, puede evolucionar a esteatohepatitis y cirrosis.\n                                                                                                                                                         Causas dependientes de la nutrición parenteral en el desarrollo de complicaciones\n         •  Emulsiones de triglicéridos de cadena larga (LCT): aportan fundamentalmente ácido lino-                                                      hepatobiliares son:\n            leico (ácidos grasos ω-6). Estos incrementan la síntesis de prostaglandinas de la serie 2                                                    •  Exceso de aporte de lípidos y glucosa.\n            (proinflamatoria). Estas emulsiones son más inestables y se peroxidan con mayor facili-                                                      •  Tipo de emulsión lipídica.\n            dad.                                                                                                                                         •  Ausencia de estímulo enteral.\n         •  Emulsiones con mezclas de LCT y triglicéridos de cadena media (MCT).                                                                         •  Infusión continua de NP.\n         •  Emulsiones enriquecidas en aceite de oliva, enriquecidas en ácido oleico.                                                                8.  Enfermedad óseo-metabólica.\n         •  Emulsiones enriquecidas en ácidos grasos ω-3.                                                                                            9.  Complicaciones asociadas al catéter.\n         Referencias:                                                                                                                                Referencias:\n         • Torres Torres B, López Gómez JJ, Gómez Hoyos E, Ortolá Buiges A, de Luis Román DA. Nutrición parenteral. En: de Luis DA, Bellido          • Torres Torres B, López Gómez JJ, Gómez Hoyos E, Ortolá Buiges A, de Luis Román\n######################\nOutput:", "parameters": {"model": "gpt-4o-mini", "temperature": 0.0, "frequency_penalty": 0.0, "presence_penalty": 0.0, "top_p": 1.0, "max_tokens": 4000, "n": 1}, "history": null}